glp-1 obesity drug news Game changing' data: New drugs tied to major weight loss, may reduce CV risk Gains clear, but no single

kids live with parents with substance use disorders People taking semaglutide had lower risk of suicidal thoughts Scientists find common brain network for substance use disorders Few are prescribed medications to treat alcohol problems Repurposed drug combats obesity in mice Alcohol-related deaths increasing nationwide Understanding alcohol use disorder Understanding alcohol drinking patterns Alcohol treatment navigator References Once-weekly semaglutide versus placebo in patients with alcohol use disorder and comorbid obesity: a randomised, double-blind, placebo-controlled trial

Table 1: Key Findings on Natural GLP-1 in Joint Fluid and Arthritis Research shows GLP-1 is present in synovial fluid , supporting the idea that therapies targeting this hormone could directly influence joint inflammation

Highlights of prescribing information

470,478,482,483,484 GLP-1RAs in the digestive system Treatment with GLP-1RAs can alleviate insulin signaling by reducing the phosphorylation of Akt protein (Decreased Akt-P) and activating Protein Kinase C- (PKC-)

doi: 10.1007/5584_2020_496 [DOI] [PubMed] [Google Scholar] 143.Hurren KM, Pinelli NR